{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Plainsboro",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75123",
      "recalling_firm": "Novo Nordisk Inc",
      "address_1": "800 Scudders Mill Road",
      "address_2": "N/A",
      "postal_code": "08536",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide and Worldwide",
      "recall_number": "D-0217-2017",
      "product_description": "GlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, Manufactured by: Novo Nordisk A/S 2880 Bagsvaerd, Denmark, NDC 0169-7065-15",
      "product_quantity": "71,215 kits",
      "reason_for_recall": "Defective delivery system: detached needles on the syringe in the kit.",
      "recall_initiation_date": "20160908",
      "center_classification_date": "20161222",
      "termination_date": "20180227",
      "report_date": "20161228",
      "code_info": "Lots: FS6X270, FS6X296, FS6X538, FS6X597, FS6X797, FS6X875; Exp 9/30/2017"
    }
  ]
}